account_balance
Investment manager · 13F filer · SEC CIK 1015083
Emerald Advisers, LLC
Reported value$3.64Bas of Sep 30, 2026
Positions224 15 new, 28 sold out
Top 10 weight17.5%TVTX alone is 3%
FiledNov 940 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
TVTXTravere Therapeutics Inc
2.5%Trimmed −2%
CORTCorcept Therapeutics Inc
2.4%
IDCCInterdigital Inc Pa Com
2.0%
SXTSensient Technologies Corp
1.7%Added +18%
COHUCohu Inc
1.6%
SMTCSemtech Corp
1.5%Trimmed −22%
PLXSPlexus Corp
1.5%
MRCYMercury Systems Inc
1.5%
VSECVse Corporation
1.5%
CECOCeco Environmental Corp
1.4%
LIVNLivanova PLC
1.4%Trimmed −14%
COGTCogent Biosciences Inc
1.4%
Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
TVTX Travere Therapeutics Inc 2.5% Trimmed −2%CORT Corcept Therapeutics Inc 2.4% HeldIDCC Interdigital Inc Pa Com 2.0% HeldSXT Sensient Technologies Corp 1.7% Added +18%COHU Cohu Inc 1.6% HeldSMTC Semtech Corp 1.5% Trimmed −22%PLXS Plexus Corp 1.5% HeldMRCY Mercury Systems Inc 1.5% HeldVSEC Vse Corporation 1.5% HeldCECO Ceco Environmental Corp 1.4% HeldLIVN Livanova PLC 1.4% Trimmed −14%COGT Cogent Biosciences Inc 1.4% Held
What changed